| Q36523475 | Autologous Skeletal Myoblast Sheet Therapy for Porcine Myocardial Infarction Without Increasing Risk of Arrhythmia |
| Q92292792 | Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology |
| Q38080896 | Bioluminescence imaging: a shining future for cardiac regeneration. |
| Q38014708 | Cell delivery routes for stem cell therapy to the heart: current and future approaches. |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q58555709 | Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies |
| Q38241994 | Cell-based therapies for cardiac disease: a cellular therapist's perspective |
| Q38859871 | Cellular Therapy for Heart Failure. |
| Q37340293 | Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design |
| Q38697092 | Current State of Stem Cell Therapy for Ischemic Heart Disease |
| Q92893361 | Effect of human thymus adipose tissue-derived mesenchymal stem cells on myocardial infarction in rat model |
| Q40301895 | Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe? |
| Q47890976 | Emerging Therapies for Congestive Heart Failure |
| Q56985687 | Global position paper on cardiovascular regenerative medicine |
| Q37353891 | Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction |
| Q27336125 | Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo |
| Q37401213 | Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease |
| Q41871018 | Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease |
| Q38596702 | Pathophysiology of Myocardial Infarction |
| Q33875374 | Pluripotent stem cell derived cardiomyocytes for cardiac repair |
| Q26823933 | Programming and reprogramming a human heart cell |
| Q38075698 | Regenerative medicine approach to repair the failing heart. |
| Q51218114 | Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. |
| Q59128840 | Therapeutic approaches for cardiac regeneration and repair |
| Q35995055 | Translational aspects of cardiac cell therapy |